Skip to content
Storytelling Co – Lifestyle
Author:
Nxera Pharma
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
May 11, 2026
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology
May 8, 2026
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
May 1, 2026
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
April 20, 2026
←
Previous Page
1
2